RI
Ridgewood Investments Portfolio holdings
AUM
$231M
1-Year Return
17.35%
This Quarter Return
+11.12%
1 Year Return
+17.35%
3 Year Return
+46.12%
5 Year Return
+86.39%
10 Year Return
–
AUM
$138M
AUM Growth
+$18.3M
(+15%)
Cap. Flow
+$6.22M
Cap. Flow
% of AUM
4.49%
Top 10 Holdings %
Top 10 Hldgs %
26.47%
Holding
201
New
26
Increased
62
Reduced
65
Closed
12
Top Buys
| 1 |
GSK
GSK
|
$1.23M |
| 2 |
Dominion Energy
D
|
$719K |
| 3 |
Perrigo
PRGO
|
$606K |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
$533K |
| 5 |
Petrobras
PBR
|
$491K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$927K |
| 2 |
Cardinal Health
CAH
|
$840K |
| 3 |
Tesla
TSLA
|
$418K |
| 4 |
Roblox
RBLX
|
$408K |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
$364K |
Sector Composition
| 1 | Financials | 26.54% |
| 2 | Healthcare | 12.93% |
| 3 | Technology | 7.95% |
| 4 | Industrials | 7.73% |
| 5 | Consumer Discretionary | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRAX
151
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
| $278K | 0.2% |
181,663
+126,843
| +231% | +$194K |
|
152
PepsiCo
PEP
$201B
| $267K | 0.19% |
1,481
| – | – |
|
153
Invesco Ultra Short Duration ETF
GSY
$2.95B
| $265K | 0.19% |
5,360
| – | – |
|
154
TriCo Bancshares
TCBK
$1.5B
| $263K | 0.19% |
5,152
-1,097
| -18% | -$55.9K |
|
|
VRE
155
Veris Residential
VRE
$1.48B
| $256K | 0.18% |
16,084
| – | – |
|
156
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.7B
| $251K | 0.18% |
2,542
| – | – |
|
157
Loews
L
$20.2B
| $250K | 0.18% |
4,293
+4
| +0.1% | +$233 |
|
158
US Bancorp
USB
$76.5B
| $245K | 0.17% |
5,613
+149
| +3% | +$6.5K |
|
159
Archer Daniels Midland
ADM
$29.8B
| $242K | 0.17% |
2,610
-541
| -17% | -$50.2K |
|
160
NVIDIA
NVDA
$4.18T
| $240K | 0.17% |
+16,390
| New | +$240K |
|
161
Progressive
PGR
$146B
| $238K | 0.17% |
1,831
| – | – |
|
162
DocuSign
DOCU
$15.4B
| $231K | 0.16% |
4,170
| – | – |
|
163
CSX Corp
CSX
$60.9B
| $228K | 0.16% |
+7,351
| New | +$228K |
|
164
RLI Corp
RLI
$6.22B
| $222K | 0.16% |
+3,388
| New | +$222K |
|
165
Research Solutions
RSSS
$107M
| $222K | 0.16% |
115,537
| – | – |
|
166
AbbVie
ABBV
$376B
| $219K | 0.16% |
+1,354
| New | +$219K |
|
167
Exxon Mobil
XOM
$479B
| $219K | 0.16% |
+1,982
| New | +$219K |
|
168
Tyson Foods
TSN
$20B
| $219K | 0.16% |
+3,511
| New | +$219K |
|
169
Pfizer
PFE
$140B
| $217K | 0.15% |
+4,233
| New | +$217K |
|
170
RTX Corp
RTX
$212B
| $214K | 0.15% |
+2,118
| New | +$214K |
|
171
Royalty Pharma
RPRX
$16B
| $212K | 0.15% |
5,370
-302
| -5% | -$11.9K |
|
172
Travelers Companies
TRV
$62.9B
| $209K | 0.15% |
+1,114
| New | +$209K |
|
173
Waters Corp
WAT
$17.8B
| $208K | 0.15% |
+606
| New | +$208K |
|
174
Sierra Bancorp
BSRR
$417M
| $208K | 0.15% |
+9,777
| New | +$208K |
|
175
Quest Diagnostics
DGX
$20.1B
| $206K | 0.15% |
1,315
-692
| -34% | -$108K |
|